International Journal of Health Research and Medico Legal Practice

Open Access Open Access  Restricted Access Subscription Access

Practice of Antenatal Breast Expression in National Health Service in England


Affiliations
1 Hinchingbrooke Hospital, NHS Foundation Trust, Hintingdon, Cambridgeshire, United Kingdom
 

Purpose: Antenatal breast expression (ABE) is widely used in National Health Services (NHS) in England without any evidence of its safety and efficacy. The purpose of this study was to investigate the extent of its use by professionals in NHS settings in England. Methods: An online questionnaire was sent to healthcare professionals involved in providing care to pregnant women in maternity units in England. Results: 56 maternity units in England with delivery rates varying from 1600 to 11,000 per annum responded to the survey including 75% response from the large hospitals. Most hospitals are offering ABE at 36-37 weeks with an aim to reduce hypoglycaemia and neonatal admissions to special care in diabetic antenatal women. Conclusion: Despite of no proven evidence of safety and efficacy, ABE is practiced in many trusts, which have huge cost and time implications, hence a clear need of evidence and guidance.

Keywords

Antenatal Breast Expression, Diabetes, Pregnancy, Hypoglycaemia, Special Care Admission.
User
Notifications
Font Size

  • Waller, H. The early failure of breast feeding: A clinical study of its causes and their prevention. Archives of Disease in Childhood 1946;21(105):1-12.

  • Waller, H.. The early yield of human milk, and its relation to the security of lactation. Lancet 1950;53-56.

  • Chapman T, Pincombe J, Harris M. Antenatal breast expression: a critical review of the literature. Midwifery 2013;29(3):203-10.

  • Kavanagh J, Kelly AJ, Thomas J. Breast stimulation for cervical ripening and induction of labour. Cochrane database of systematic reviews 2005 issue 3.

  • Forster DA, McEgan K, Ford R, Moorhead A, Walker S, McNamara C. Diabetes and antenatal milk expressing: a pilot project to inform the development of a randomised controlled trial. Midwifery 2011;27:209-14.

  • Bell R, Glinianaia S, Tennant P, Bilous R, Rankin, J. Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia 2012;55(4):936-947.

  • Confidential Enquiry into Maternal and Child Health. Diabetes in pregnancy: Are we providing the best care? Findings of a National Enquiry: England, Wales and Northern Ireland. London CEMACH, 2007.

  • Arthur P, Kent J, Hartmann. Metabolites of lactose synthesis in milk from diabetic and nondiabetic women during lactogensis II. J.Pediatr. Gastro-enterol Nutr 1994;19:100-108.

  • NICE. Diabetes in pregnancy: Management of diabetes and its complications from pre-conception to the postnatal period. 2008.

  • East CE, Dolan WJ, Forster DA. Antenatal breast milk expression by women with diabetes for improving infant outcomes. Cochrane Database Syst Rev.2014.

  • Soltani, H. and Scott, A. Antenatal breast expression in women with diabetes: outcomes from a retrospective cohort study. Int Breastfeed J 2012;7-18.


Abstract Views: 196

PDF Views: 84




  • Practice of Antenatal Breast Expression in National Health Service in England

Abstract Views: 196  |  PDF Views: 84

Authors

Pathak Sangeeta
Hinchingbrooke Hospital, NHS Foundation Trust, Hintingdon, Cambridgeshire, United Kingdom

Abstract


Purpose: Antenatal breast expression (ABE) is widely used in National Health Services (NHS) in England without any evidence of its safety and efficacy. The purpose of this study was to investigate the extent of its use by professionals in NHS settings in England. Methods: An online questionnaire was sent to healthcare professionals involved in providing care to pregnant women in maternity units in England. Results: 56 maternity units in England with delivery rates varying from 1600 to 11,000 per annum responded to the survey including 75% response from the large hospitals. Most hospitals are offering ABE at 36-37 weeks with an aim to reduce hypoglycaemia and neonatal admissions to special care in diabetic antenatal women. Conclusion: Despite of no proven evidence of safety and efficacy, ABE is practiced in many trusts, which have huge cost and time implications, hence a clear need of evidence and guidance.

Keywords


Antenatal Breast Expression, Diabetes, Pregnancy, Hypoglycaemia, Special Care Admission.

References